Nicox: collaboration agreement with Re-Vana.
(CercleFinance.com) - The international ophthalmic company Nicox has announced that it has concluded a research collaboration agreement with Re-Vana Therapeutics Ltd, Re-Vana Therapeutics Ltd, a UK ocular pharmaceutical and drug delivery company.
This non-exclusive collaboration will focus on the development of EyeLief, an extended-release drug delivery platform, applied to Nicox's new generation pure nitrous oxide donors.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
This non-exclusive collaboration will focus on the development of EyeLief, an extended-release drug delivery platform, applied to Nicox's new generation pure nitrous oxide donors.
Copyright (c) 2017 CercleFinance.com. All rights reserved.